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ABSTRACT
Pre-eclampsia is increasingly recognized as more than an isolated disease of pregnancy. Women
who have had a pregnancy complicated by pre-eclampsia have a 4-fold increased risk of later
cardiovascular disease. Intriguingly, the offspring of affected pregnancies also have an increased
risk of higher blood pressure and almost double the risk of stroke in later life. Experimental
approaches to identify the key features of pre-eclampsia responsible for this programming of
offspring cardiovascular health, or the key biological pathways modiﬁed in the offspring, have the
potentialtohighlightnoveltargetsfor early primarypreventionstrategies.Aspre-eclampsiaoccurs
in 2–5% of all pregnancies, the ﬁndings are relevant to the current healthcare of up to 3 million
people in the U.K. and 15 million people in the U.S.A. In the present paper, we review the current
literature that concerns potential mechanisms for adverse cardiovascular programming in offspring
exposed to pre-eclampsia, considering two major areas of investigation: ﬁrst, experimental models
that mimic features of the in utero environment characteristic of pre-eclampsia, and secondly, how,
in humans, offspring cardiovascular phenotype is altered after exposure to pre-eclampsia. We
compare and contrast the ﬁndings from these two bodies of work to develop insights into the
likely key pathways of relevance. The present review and analysis highlights the pivotal role of long-
term changes in vascular function and identiﬁes areas of growing interest, speciﬁcally, response to
hypoxia, immune modiﬁcation, epigenetics and the anti-angiogenic in utero milieu.
CLINICAL IMPORTANCE
Traditionally pre-eclampsia was viewed as a self-
limiting maternal condition that resolved completely
with delivery of the placenta [1,2]. However, it is
now recognized that a woman who has a pregnancy
complicated by pre-eclampsia [3,4] has a 4-fold increased
risk of hypertension, and a 2-fold increased risk of
ischaemic heart disease and stroke [3] in the 10–15 years
after the pregnancy. Intriguingly, the offspring of that
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pregnancy will also have increased BP (blood pressure)
during childhood and nearly double the risk of stroke
in later life [5–16]. As pre-eclampsia affects 2–5% of
pregnancies, 1.2–3 million people in the U.K. and 6–15
million in the U.S.A. [1,2] are offspring of pregnancies
complicated by pre-eclampsia. Experimental approaches
to identify the key biological variation that infer
the increased risks in this large cohort therefore have the
potential to pivotally alter our understanding of the early
development of cardiovascular disease and hypertension
in the population. The fact that exposed children and
adults can be easily identiﬁed based on precise clinical
criteria, namely a diagnosis of pre-eclampsia in their
mother, also raises the possibility for novel, very early,
targeted,primarypreventionstrategiesforcardiovascular
risk reduction in a high risk group within the community
[17].
EPIDEMIOLOGICAL CLUES TO THE
MECHANISM
The epidemiological data used to uncover the rela-
tionships between maternal pre-eclampsia and offspring
cardiovascular health provide clues to the broad nature
of the biological variation that underlies the risk [15].
Meta-analysis of available BP data indicates that children
exposed to pre-eclampsia in utero have approximately 2–
3 mmHg higher SBP (systolic BP) during childhood and
young adult life [18]. This difference, if maintained into
adulthood, would be associated with a 12% increased
risk from stroke [19,20]. In reality, long-term follow-
up studies demonstrate a doubling of risk [6]. The key
biological pathways relevant to offspring cardiovascular
health are therefore likely to have additional effects, on
other features of stroke risk, beyond clinic BP measures
alone.
Pre-eclampsia is a condition with a heritability of
approximately 55% [21], which is contributed to by
both maternal and fetal genes. It is plausible that some
of the alterations in risk seen in the offspring of pre-
eclamptic pregnancies relate to shared genetic factors
between the mother and child. The modiﬁcation to these
pathways also appears to be induced speciﬁcally by in
utero exposure to pre-eclampsia. Siblings of offspring
born to pregnancies complicated by pre-eclampsia, who
themselves were born to uncomplicated pregnancies,
do not demonstrate the vascular abnormalities seen in
the offspring [11]. This observation has clear parallels
with the ‘developmental programming’ hypothesis [22],
which holds that an insult or deprivation during a critical
period of growth and development can lead to long-
term alterations in the risk of chronic disease [23]. This
hypothesis was developed in response to epidemiological
data that associated a low birthweight, a pregnancy-
related outcome with multi-factorial determinants, to
a variety of cardiovascular and non-cardiovascular
outcomes, including mortality from coronary artery
disease [24,25], BP [24], the metabolic syndrome [26] and
non-insulin-dependent diabetes (Type 2 diabetes) [27].
Offspring of pre-eclamptic pregnancies, particularly
those with early-onset pre-eclampsia, can also have a
low birthweight due to IUGR (intra-uterine growth
restriction) or pre-term birth [23]. Prematurity and
IUGR have themselves been associated with alterations
in cardiovascular risk factors [28,29]. Furthermore,
early-andlate-onsetpre-eclampsiaareincreasinglybeing
recognized as different subclasses of disease, which may
have different implications for cardiovascular risk in the
offspring [30]. This complicated combination of in utero
insults means that in many currently available human
studies it is challenging to separate the effects of exposure
to pre-eclampsia from other in utero insults. However,
if a baby is born at term without IUGR, but their
mother had pre-eclampsia, they still have an increased
risk of stroke [6] and vascular abnormalities [31] that
persist after adjustment for birthweight. It therefore
seems plausible that there is a unique insult within
the in utero environment during pre-eclampsia which is
incremental to, or acts in synergy with, any risks inferred
by IUGR. This hypothesis is supported further by the
observation that pre-term birth largely protects offspring
from the adverse associations between birthweight and
later cardiovascular disease [24,32]. Pre-eclampsia is one
of the leading causes of pre-term birth, and the largest
differences in later BP are seen in those offspring of pre-
eclamptic pregnancies born pre-term [12]; ﬁndings that
focus attention on key insults that may operate early in
pregnancy.
On the basis of these observations, we have now
gone on to review the current experimental literature
to gain insight into potential mechanisms for in utero
cardiovascularprogramminginrelationtopre-eclampsia.
Wehavefocusedonexperimentsthatusemodelsdesigned
to replicate features of pre-eclampsia, in particular the
early detrimental exposures that characterize the fetal
experience in this condition. We have compared the
ﬁndings with those from human studies of offspring, or
tissues, from pre-eclamptic pregnancies. The cumulative
body of work supports associations between pre-
eclampsia exposure and offspring cardiovascular health,
as well as a potential pivotal role for long-term
programmed changes in vascular biology (Table 1 and
Figure 1).
THE IN UTERO INSULT
Disturbed placentation in early pregnancy is considered
the key pathological event that leads to subsequent
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Table 1 Evidence of cardiovascular programming following pre-eclampsia
An overview of some of the evidence for cardiovascular programming in offspring of animal models and humans born to pre-eclamptic mothers. Positive ﬁndings are underlined in roman and negative ﬁndings are indicated in italic.
Human offspring
Animal model offspring Perinatal Later life
Parameter RUPP Hypoxia sFLT1 eNOS Placenta Cord blood HUVECs Neonate Childhood Adolescence Young adult
BP
↑BP [63–65] [72,100] [78,181] [82,182] – – – [183] [114,184] [11] [12]
[54–58,60–62,159,160,162,180] [10,15,177,178,185] [7,8,13,14]
Altered BP under stress – – [72] [82]– – – – – – –
Vascular structural changes
↑IMT/vascular wall thickness [63,64,86] [87–89] – – – – – [92] – – [12]
↑Arterial stiffness [55,63] [69] – [186] –– – –[15] – [12]
[113]
Vascular functional changes
Endothelial dysfunction [63,141] [69–71] – [112,113,182,186] – [116] [187] [31] [15] [11] [12]
[54,110]
Non-endothelial function [110,141] [71] [188] [113,182] –– – –– [11] [12]
Cardiac structural and functional
changes
Altered cardiac structure [65] [72,95–98] [181] –– – – – [105] ––
[57,86]
LV dysfunction – [95] – – – – – [189] [105] ––
↑IR injury – [94,99–101,190] –– –– – – – – –
Renal structural and functional
changes
Altered structure and function [59,62,65] – [191] –– – – – – – –
[57,58,61,64,65,86,159–161]
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Table 1 Continued
Human offspring
Animal model offspring Perinatal Later life
Parameter RUPP Hypoxia sFLT1 eNOS Placenta Cord blood HUVECs Neonate Childhood Adolescence Young adult
Metabolic changes
↑BMI [54,56–59,62,65,86, [71,72,88,94,95, [77,181,188] [82,113] –– – [92] [178,184] [11,14] [12]
110,180,192,193] 100,131,196] [7,8,10,15] [16] [13]
[194,195]
↑Serum lipids [56,63,195] [196] [181] – – [92,126–130] –– [15] [14] [12]
[131] [114]
Altered glucose metabolism [63] [196] [181] – – – – – – [14] [12]
[56,194,195,197]
Altered sympatho-adrenal function
Adrenal hormones [62,161,195] [72,155,157] – – – [198,199] –– –[154] –
[14]
Sympathetic changes [200] [72,158] –– – – – – – – –
Genetic/epigenetic changes
Gene expression [57,61,65,160,161]
[62,63,159]
[96,97,100,131,
190,196]
– [191] [67,103,164,201–206] –– – – – –
Epigenetics – [101] – – [135–137] –– – – – –
Other
↓Antioxidants – – – – [207] [127,147] –– –––
↑Oxidative stress [56] – – – [148] [127,147,148] –– –––
↑Anti-angiogenic factors – – – – – [120,121] –– [114] ––
↑PlGF/VEGF – – – – – [120] –– [114] ––
Altered inﬂammation [63] [131] [181] – – – [173–176] [208] [15,114] ––
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Figure 1 Potential mechanism of cardiovascular programming in the offspring following a pre-eclamptic pregnancy
Summary of the potential and demonstrated mechanisms by which in utero exposure to pre-eclampsia may lead to altered cardiovascular physiology and risk in the
offspring in later life.
development of pre-eclampsia [2,33]. Normal placental
development is characterized by invasion of maternal
spiral arteries by fetal cytotrophoblasts and their trans-
formation into high-calibre capacitance vessels, which
provides low-resistance placental perfusion to sustain
fetal growth [34]. In pre-eclampsia, the spiral arteries
inadequately remodel so that uterine ﬂow is reduced by
50% and there is chronic placental ischaemia or, at best,
intermittent ﬂow that induces an ischaemia/reperfusion
phenomenon [35]. ROS (reactive oxygen species) and cy-
tokinesreleasedfromtheischaemicplacentatriggerasys-
temic oxidative [36] and inﬂammatory [35,37] state. The
placenta also overexpresses anti-angiogenic factors that
inhibit the normal function of pregnancy-related pro-
angiogenicfactors,includingVEGF(vascularendothelial
growth factor) and PlGF (placental growth factor) [38].
The combination of these factors is believed to underlie
the systemic endothelial dysfunction that is consist-
ently found during symptomatic pre-eclampsia in the
mother.
Offspring of pre-eclamptic pregnancies therefore
develop from the ﬁrst trimester onwards within an envir-
onment of placental insufﬁciency and restricted oxygen
supply. By the start of the second trimester there is, in
addition,exposuretoelevatedcirculatinganti-angiogenic
factors, which predates the later emergence of the clinical
pre-eclamptic syndrome and the diffuse maternal inﬂam-
matory, oxidative and dysfunctional endothelial state.
Experimental studies have an important role to help us
understand how, and whether, these speciﬁc insults have
an impact on the developing cardiovascular system of the
offspring. Their ﬁndings have the potential to unravel the
developmental programming that underlies the observed
long-term cardiovascular disease risk in the offspring.
However,theidealanimalmodelofpre-eclampsiadoes
not exist, in part because the spontaneous development
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of pre-eclampsia during pregnancy is a condition
largely unique to humans [39,40]. To mimic the human
syndrome a model would need to be characterized by
the development of pregnancy-speciﬁc hypertension,
proteinuriaandassociatedalterationsinvascularfunction
andbiomarkers.Toreplicatetheconditionperfectly,these
changes must be secondary to impaired trophoblastic
invasion [40]. Although a variety of models based on
differentaspectsofthepathophysiologyofpre-eclampsia
exist[39,40],nomodelhasbeenabletosuccessfullymimic
all of the pathophysiological features of pre-eclampsia or
to accurately replicate the ﬁrst trimester origin of the
human condition. For example, the currently available
animal models are limited in their capacity to produce
the metabolic alterations which are evident in human
pre-eclamptic pregnancies [41,42]. Another limitation
is that the models have been primarily developed to
investigate pre-eclampsia in the mother not the offspring.
However, fortuitously, the adequacy of animal models
developed to study pre-eclampsia has, in part, been
deﬁned by their ability to induce IUGR. As a result,
these ‘pre-eclampsia’ models have been adopted to
study how IUGR has an impact on the offspring [43].
The ﬁndings from these offspring studies, in particular
those that maintain experimental set ups that would be
expected to induce pre-eclampsia-like syndromes in the
dams, thereby provide insights into the role of pre-
eclampsia-related insults. We have used data available
from animal models to dissect out whether there is
evidence that key features of the pre-eclamptic in utero
environment induce long-term changes characteristic of
the cardiovascular risk phenotype seen in offspring
ofpre-eclampticpregnancies,namelyelevatedrestingBP.
Uterine perfusion
Mechanical reduction in maternal uterine artery blood
ﬂow [RUPP (reduced uterine artery perfusion)], by
unilateral or bilateral uterine artery ligation, in animal
models induces a pregnancy-speciﬁc increase in maternal
BP [44]. The model is well established and has been
applied in a range of species from initial work in dogs
to rats [40], rabbits [45], sheep [46], guinea-pigs [47] and
non-humanprimates[48].Indogs,othercardinalfeatures
of pre-eclampsia are evident such as renal glomerular
endotheliosis and, in some instances, proteinuria [49].
In rats, RUPP pressure between days 14 and 19
of pregnancy induces a full pre-eclampsia pregnancy
phenotype, including markedly elevated BP and changes
in renal artery ﬂow and glomerular ﬁltration rate [50].
Furthermore, other distinct biological changes occur in
the mother, speciﬁcally dysfunction of endothelium-
dependent vascular relaxation [51,52] and increased
circulating levels of sFlt-1 (soluble fms-like tyrosine
kinase-1) with a resultant reduction in VEGF and PlGF
[53].
Variations of the RUPP model have been used to
study the inﬂuence of reduced uterine perfusion on
offspring BP and, interestingly, BP does not differ
from controls in a large number of the studies [54–62].
Variation in the species investigated or techniques for BP
measurement have been postulated to account for this
disparity from the observations in humans. However,
when all of the studies are considered together (Figure 2),
the time when uterine perfusion is reduced appears to
be critical. If at 14 days into gestation, changes in resting
BP are consistently evident in the offspring throughout
life. When uterine perfusion is only introduced late in
gestation,despiteinducinggrowthrestriction,thestudies
show either no increase in BP or modest changes in
later life that may require stimuli to elicit variability
[63–65]. These ﬁndings argue for early exposure to
uterine perfusion abnormalities to be critical to the BP
programming in the offspring. However, early ligation
has been associated with the full range of pre-eclampsia-
like features in the dams, including deranged anti-
angiogenic factors and vascular dysfunction. Therefore
an evaluation of the speciﬁc relevance of the individual
insults is not possible from this model.
Hypoxia
Placental insufﬁciency is likely to lead to offspring of
pre-eclamptic pregnancies developing in an environment
of signiﬁcant hypoxia from early in pregnancy. In all
pregnancies, early placental development takes place
under low oxygen conditions as this predates the
formation of an effective maternal–fetal circulation
[66,67]. Even in later stages of normal pregnancy,
fetuses whose mothers have normal placental perfusion
and breathe 21% inspired O2 are still exposed to
intervillous oxygen levels equivalent to only 8–11% O2.
The abnormal placentation in pre-eclampsia is therefore
likely to result in signiﬁcantly lower oxygen delivery to
the fetus for the majority of gestation. Interestingly, even
in pregnant mice with normal placental development,
exposure to an inappropriate level of hypoxia from
early in pregnancy (9.5% O2 from day 7.5 to day
17 of gestation) induces a range of pre-eclampsia-
like symptoms in the mother, including hypertension,
proteinuria, IUGR, renal pathology and elevations in
maternal sEng (soluble endoglin) [68]. The underlying
reason for this is not clear, although it could be because
the degree of hypoxia induced at the level of the placenta
is sufﬁcient to trigger the ‘pre-eclampsia cascade’ of
events, similar to that present in a mother with abnormal
placental development. Consistent with this hypothesis,
lessseverehypoxia(11%O2)orhypoxialateringestation
(9.5% O2 from day 10 or 15 to day 17 of gestation) does
not induce these changes [68].
When the data from models of pregnancy hypoxia
are collated (Figure 3), despite a range of changes in
other cardiovascular measures, there is a striking lack of
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Figure 2 Timing of the reduction in uterine artery perfusion and offspring BP
Summary of the results of studies (reference number given) considering the effect of RUPP at different points of gestation on offspring BP. Continuous lines indicate
that studies have demonstrated an increase in BP in RUPP animals compared with controls at this time point, whereas broken lines indicate no differencei nB P
compared with controls. The colour of the lines indicates the timing of the in utero insult; the red line showing the result of studies in which uterine artery perfusion
was reduced at day (D) 14, the blue line at day 18 and the green line at day 19 of gestation. This suggest that the timing of the insult may be critical in determining
the effect on offspring BP. Studies of mid-gestation (14 days of gestation) reduction in uterine artery ﬂow have demonstrated relatively consistent increases in BP from
early life (4 weeks of age). Interventions later in gestation (days 18 and 19 of gestation) have not indicated consistent increases in early life, although some studies
have indicated later development of hypertension which may be linked to dietary factors.
any consistent reports of elevated BP in the offspring.
This may be because the majority of studies are based
on the use of oxygen concentrations higher than 9.5%
and/or exposed animals later in pregnancy [69–71]. Even
in models in which oxygen availability is reduced early in
development (days 5–20 of pregnancy), the level of
maternal hypoxia (10% O2) has been relatively higher
than that normally associated with induction of a pre-
eclampsia-like syndrome in the mother. BP variation in
the offspring has been demonstrated in response to stress
[72], butthis BPphenotype is distinctfromthat observed
in human offspring of pre-eclamptic pregnancies, who
have increased resting BP in early life [18]. These
ﬁndings may suggest that hypoxia alone is insufﬁcient
to induce the long-term effects of pre-eclampsia seen in
the offspring, or that the levels of hypoxia currently used
are not representative of the levels offspring are exposed
to during development.
Anti-angiogenic factors
Multiple studies have now demonstrated a key step
in the progression of pre-eclampsia from placental
underperfusion and hypoxia to a clinical syndrome is an
increase in levels of circulating anti-angiogenic factors.
These include sFlt-1, the alternatively spliced truncated
form of VEGF receptor 1 [73], and sEng [74–76]. sFlt-
1 inhibits the normal function of pregnancy-related
angiogenic factors, including VEGF and PlGF [38], and
a Sprague–Dawley model of pre-eclampsia based on
adenovirus vector administration of sFlt-1 early in the
second trimester (days 8–9 of pregnancy), when the
levels are seen to increase in human pregnancy, has been
developed [74]. This model overexpresses sFlt-1 and the
transfected rats develop hypertension, heavy proteinuria
and glomerular endotheliosis. These signs also occur in
non-pregnant rats treated with sFlt-1 [74], indicative of
thebroaderrelevanceofderangedanti-angiogenicfactors
to vascular homoeostasis. The same intervention in mice
induces a slightly different phenotype with maternal
hypertension, fetal growth restriction and impairment
of maternal platelet count [77]. Lu et al. [78] have
investigated the effect of administration of an adenovirus
carrying sFlt-1 to pregnant mice on offspring BP over
the ﬁrst 6 months of life. They found a sustained increase
in BP in male offspring evident from the ﬁrst day of
life, which persisted during the period of measurement.
As with other models of pre-eclampsia, a range of
clinical features of the condition are induced [79] and
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Figure 3 Cardiovascular changes associated with in utero exposure to hypoxia
The major ﬁndings from studies (reference number given) considering the effects of pre-natal chronic hypoxia at different points of gestation on offspring cardiovascular
physiology are outlined. The colour of the lines indicates the timing of commencement of in utero hypoxia; The dark blue line indicates hypoxia for the entire period
of gestation, the green line from day 5, the red line from day 6, the purple line from day 7, the orange line from day 15, and the pale blue line from day 18
of gestation. The percentage of oxygen used in each study is indicated above the lines. Studies have been divided into those where hypoxia was commenced
in early pregnancy (before day 10 in rat models or from conception in other animals) and those where hypoxia was commenced later in
pregnancy. Studies later in pregnancy have demonstrated vascular, cardiac and metabolic alterations in the offspring. Fewer studies have considered the effects
of early-onset hypoxia, but these have demonstrated similar ﬁndings in terms of the vascular phenotype.
speciﬁcculpabilityforsFlt-1inprogrammingofoffspring
cardiovasculaturecannotbeconﬁrmed.Nevertheless,the
results suggest that, even with normal placentation and
uterine blood ﬂow in early pregnancy, exposure to an
excess of anti-angiogenic factors, speciﬁcally raised sFlt-
1 and its biological sequelae, is sufﬁcient to induce long-
term changes in BP in the offspring.
Systemic endothelial dysfunction
The speciﬁc role of systemic maternal endothelial
dysfunction is relatively simpler to explore. This is
because targeted animal models are available that allow
in utero development in a mother with endothelial
dysfunction to be studied. These models are based
either on systemic inhibition of eNOS (endothelial NO
synthase) by administration of l-NAME (NG-nitro-l-
arginine methyl ester) or by eNOS knockout [39]. A
limitation is that these are not good models of pre-
eclampsia itself as the hypertension in eNOS-knockout
mice [80] is not pregnancy-speciﬁc and, indeed, one
studyhasreportedthateNOS-knockoutmothershaveno
differenceinBPduringpregnancy[81].Nevertheless,the
mice consistently exhibit abnormal endothelial function
and, through selective breeding of an eNOS-knockout
mother with a wild-type male, an experimental scenario
can be generated to study the impact of maternal
endothelial dysfunction on the in utero development
of an eNOS-heterozygous offspring (Figure 4). These
offspring have higher BP during adulthood than the
genetically similar offspring bred from a wild-type
motherandaneNOS-knockoutfather,whodifferonlyin
thattheirinuterodevelopmentwasinawild-typemother
with normal endothelial responses [82]. Such ﬁndings
highlight the potential pivotal importance of maternal
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Figure 4 Effect of maternal systemic endothelial dysfunction during pregnancy on offspring BP
Experiments in eNOS-knockout mice have demonstrated the importance of the development in an environment of maternal systemic endothelial dysfunction.
eNOS-knockout heterozygotes born to knockout mothers have shown some evidence of increased BP and BP variability compared with heterozygotes gestated in an
environment with normal endothelial function. Second-generation offspring also show alterations in BP. Maternal systemic endothelial dysfunction during pregnancy is
characteristic of the human syndrome of pre-eclampsia and these models highlight the potential importance of this in utero insult on later offspring vascular function
[82].
endothelial dysfunction during pregnancy, even in the
absence of other pre-eclamptic features, on long-term
offspring outcome.
MECHANISM OF LONG-TERM PROGRAMING?
THE CARDIOVASCULAR SYSTEM
The data from available animal models implicate reduced
uterine perfusion, if present from early in pregnancy,
as well as exposure to anti-angiogenic factors and
systemicendothelialdysfunction,fromatleastthesecond
trimester, as capable of inducing long-term changes in
BP in offspring. The evidence for a speciﬁc effect of
hypoxia is weaker in current animal models, although
some changes in BP response if hypoxia occurs from
early in pregnancy is observed. To understand how
these insults during pregnancy might lead to long-
term alterations in BP, a more in-depth study of the
cardiovascular phenotype that might be relevant to BP
in these experimental models is required.
Vascular structure
A key determinant of BP in humans is arterial stiffness,
with increased arterial stiffness being associated with
elevationofcentralBPs[83,84].Thereforeonepossibility
is that exposure to the abnormal intra-uterine milieu of
pre-eclampsia leads to vascular structural remodelling
that persists into post-natal life [85]. One RUPP model
study has evaluated the stress–stain relationship of
offspring arteries and found evidence of increased aortic
stiffness, as well as greater elastic ﬁbre content in the
vessel wall [63]. Apparently in support of the hypothesis
that pre-eclamptic insults induce structural changes in
blood vessels are ﬁndings from a guinea-pig model
of RUPP-exposed offspring, which showed increased
thickness of the aortic media [86]. Offspring of dams,
hypoxic from early in gestation, were also found to have
a thicker aortic media with increased smooth muscle
cell density in fetal life [87,88]. However, changes in
arterial stiffness are not found in studies of human
offspring in adolescence (14 years of age) [11] or young
adulthood(20–30 yearsofage)[12]and,inanimalmodels,
by adult life, 16-month-old offspring of hypoxic dams
start to exhibit quite distinct vascular structural changes
with oedematous and necrotic aortic endothelium and
disarranged proliferative smooth muscle cells [89]. These
ﬁndings are more characteristic of atherogenic vascular
remodelling rather than the vascular structural matrix
changes associated with abnormal arterial stiffness [84].
Other studies of rat RUPP offspring have also identiﬁed
anincreasedpropensitytodeveloparterialinternalelastic
lamina lesions, an early atherosclerotic process, when
studied at 8 and 16 weeks of age [64].
These observations highlight development of an
early atherogenic phenotype, independent of BP, as an
additionalpotentiallinkbetween pre-eclampsiaexposure
and later cardiovascular disease. Atherosclerosis in
humans is characterized by thickening of the arterial
intima media, which can be evaluated non-invasively
by ultrasound [90], and carotid artery IMT (intima-
media thickness) associates with the extent of coronary
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artery disease [90,91]. Consistent with the observations
in animal studies, offspring of pre-eclamptic pregnancies
also show an increased IMT in their 20s [12] with aortic
arterialthickeningalreadyevidentatbirth[92].Therefore
the features of vascular remodelling that have been
observedarepredominantlynotthoseassociatedwiththe
arterial stiffening that underlies BP variation. However,
thereappeartobesigniﬁcantearlyatherosclerosis-related
changes in the vascular wall, the importance of which
require further exploration.
Cardiac structure
An alternative possibility to explain the variation
in BP is that the in utero insult alters cardiac
development.Thestructuralandfunctionalchanges,such
as increased cardiac output or LVH [LV (left ventricular)
hypertrophy], then predispose to development of
hypertension [93]. Hypoxic exposure in pregnancy does
lead to abnormalities in cardiac appearances, although
these seem to be predominantly of a cardiomyopathic
phenotypemorecommonlylinkedwiththedevelopment
of heart failure. Rat offspring exposed to hypoxia
during late gestation have increased cardiac size
relative to body weight [89,94–96], with reduced LV
wall thickness, reduced cardiomyocte proliferation and
epicardial detachment [96,97]. It has been hypothesized
that this detachment of the epicardium in fetal life
[97] may be mechanistically related to the changes in
the myocardium, as the epicardium is a major source
of growth factors during cardiac development [96,97].
Higher levels of apoptotic proteins and induction of HIF
(hypoxia-inducible factor)-1α are also evident and may
drive some of this process [98,99].
Additionally, offspring cardiac collagen content can
be altered by maternal hypoxia, with rats exposed to
hypoxia during late gestation having increased cardiac
levelsofcollagenIandIII[96,100].Theseanimalsexpress
a complex array of alterations in extracellular matrix
regulation so that, by day 21, rat fetuses exposed to
hypoxiahavedecreasedMMP(matrixmetaloproteinase)-
1 and increased MMP-13 and TIMP (tissue inhibitor
of metalloproteinases)-3 and TIMP-4. In neonatal life,
both MMP-1 and MMP-13 levels are still raised and
at 4 months of age MMP-2 levels are reduced [96,100].
Another potential link between in utero hypoxia and
later cardiovascular disease is through alterations in
cardiac ischaemia/reperfusion mechanisms. Speciﬁcally,
rats exposed to hypoxia in late gestation have been found
to have alterations in cardiac proton production and
increased myocardial production of acetyl-CoA during
reperfusion [94,99]. In fetal life, such animals also have
a signiﬁcant reduction in cardiac PKCε (protein kinase
Cε), possibly secondary to increased methylation at the
PKCε promoter site [101]. As PKCε plays a critical
role in cardioprotection during ischaemia [102], this may
underlie the observed differences.
However, these ﬁndings need to be interpreted with
caution in relation to pre-eclampsia. None of the studies
haveinvestigatedlowlevelsofhypoxiaearlyinpregnancy
and the data for long-term changes in cardiac function
are variable. Offspring of Sprague–Dawley rats exposed
to hypoxia (12% O2) from days 15 to 21 of pregnancy
showed no differences from controls in cardiac function
at 4 months of age, as assessed by echocardiography, but,
by 12 months, male offspring only demonstrated signs of
LVH. In a second study, both male and female offspring
had structurally similar hearts, but those exposed to
hypoxia had impaired diastolic function and evidence of
pulmonary hypertension in later life [95].
In humans, placental tissue from pre-eclamptic
pregnancy has differential expression of genes associated
with cardiovascular development [103]. However, an
18-year follow-up of children born to hypertensive
pregnancies did not show differences in LV mass, as
assessed by echocardiography [104]. More recently, one
studyinchildrenaged5–8 yearsexposedtopre-eclampsia
in utero found they had smaller hearts, increased heart
rateandincreasedlatediastolicvelocityatthemitralvalve
attachments[105].Overall,apragmaticconclusionisthat
moredetailedworkisneededtounderstandwhetherpre-
eclampsia leads to cardiac changes in humans. If so, the
geometriccardiacchangesobservedsofararelikelytobea
distinct pathway to disease, or secondary to BP variation,
rather than the primary underlying mechanism for the
hypertensivephenotypeoftheoffspringofpre-eclamptic
pregnancies.
Vascular function
One possibility is that the variation in BP is
driven by underlying induced abnormalities in vascular
function, rather than structural cardiovascular changes.
In particular, systemic endothelial function is associated
with traditional cardiovascular risk factors, including
hypertension [106]. Endothelial dysfunction is also
an early biological factor in the development of
atheroscleroticvasculardisease[107,108]andpredisposes
to the development of LVH [109]. Consistent with
vascular function being a central factor in the association
between pre-eclampsia and long-term cardiovascular
health, abnormalities in vascular responses are found in
nearly all offspring models that mimic pre-eclampsia, as
well as the majority of human studies of offspring of pre-
eclamptic pregnancies. RUPP offspring have enhanced
vascular contraction in response to phenylephrine and
a reduction in endothelium-dependent relaxation during
early life [54,63,110]. Lower ﬂow-mediated vasodilation
is also evident up to 12 months of age in rats born
to mothers housed under hypoxic conditions, even if
only during late gestation (days 15–21 of pregnancy)
with relatively high oxygen levels (11.5–12% O2)
[69,70]. In more speciﬁc ‘pre-eclampsia’ models, long-
term effects on endothelial responses are the major
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adverse change reported in cardiovascular phenotype
of male offspring of sFlt-1-induced ‘pre-eclamptic’
mothers. They exhibit the same pattern of higher
responses to phenylephrine and reduced vasorelaxation
in response to acetylcholine [111] observed in the
RUPP offspring model. Mice heterozygous for eNOS,
whosemotherswereeNOS-knockoutandthereforewho
developed in an in utero environment of endothelial
dysfunction, similarly have enhanced phenylephrine-
induced contraction and reduced acetylcholine-mediated
relaxation compared with heterozygous mice with wild-
type mothers [112,113].
This ﬁnding is also evident in humans, with young
adults(20–30 yearsofage)bornpre-termtohypertensive
pregnancies having a distinct vascular phenotype when
compared with those born pre-term to normotensive
pregnancies, despite both groups demonstrating a similar
magnitude of increase in BP when compared with term-
born controls [12]. Only those born to hypertensive
pregnancies had evidence of impaired ﬂow-mediated
endothelialresponses.Offspringofpre-eclampticwomen
also have impaired endothelial function in childhood (5–
8 years of age) [114] and adolescence (14 years of age)
[11]. Only one study, in children between 9 and 10 years
of age, has not been able to demonstrate this difference in
endothelial response [15]. Recently, it has been reported
thatthereareendothelium-dependentdifferencesevident
withinthemicrovasculatureinoffspringofpre-eclamptic
pregnancies during neonatal life [115], and evidence has
been found of endothelial activation at birth based on
cord blood analysis [116].
Experimental studies provide some insight into the
potential underlying vascular abnormality. In arterial
segments from RUPP model offspring, both basal and
acetylcholine-induced NO production is reduced and
arterialsegmentsfromRUPPanimalsdonotdemonstrate
the normal impairment of acetylcholine-induced vas-
odilation after l-NAME pre-treatment [54]. This latter
observation suggests there may also be a compensatory
up-regulation of NO-independent pathways to maintain
the vasodilation response. This loss of NO-mediated
vasomodulation due to reduced NO production also
underlies the vascular dysfunction demonstrated in
several studies of rats exposed to hypoxia in utero [69–
71,117] and has been observed in studies of HUVECs
(human umbilical vein endothelial cells) grown from
umbilical cords from pre-eclamptic pregnancies [118].
What might underlie the reduced NO synthesis? A
characteristic feature of pre-eclampsia is a derangement
of circulating anti-angiogenic factors. Elevated sEng
in the pre-eclamptic mother, with resultant alterations in
TGF (transforming growth factor)-β signalling, has been
directly implicated in reduced NO bioavailability in
the mother. Persistent abnormalities in anti-angiogenic
factors in the offspring could therefore lead to persistent
endothelial dysfunction in later life. Studies during
neonatal life demonstrate that the fetus is exposed to
elevatedanti-angiogenicfactorsinutero,asamnioticﬂuid
levels of sFlt-1 are higher in pre-eclamptic pregnancies
[119] and neonates born to pre-eclamptic pregnancies
have signiﬁcantly higher circulating sFlt-1 and sEng, as
wellaslowerVEGFandPlGFlevels[120,121].However,
to date, the only study of anti-angiogenic factors in
children of 5–8 years of age has demonstrated no long-
term differences [114].
One possibility is that in utero exposure to anti-
angiogenic factors leads to altered in utero endothelial
development and physiology. Consistent with this hypo-
thesis,sFlt-1administeredinvitroinhibitsendothelialcell
proliferation and tubule formation [122]. HUVECs from
pre-eclamptic donors also appear to differ from normal
in their response to oxygen levels. Under normoxic
conditions,theydevelopahighernumbersofconnections
and shorter tubule lengths, creating networks similar
to those seen when control cells were grown under
hypoxic conditions [118]. These ﬁndings suggest that
endothelial cells from pre-eclamptic pregnancies may
be ﬁxed in a ‘hypoxic’ phenotype. This ‘hypoxic’
programming may not be endothelium-speciﬁc, as gene
expression in pre-eclamptic placentae is also similar to
that seen in control placental explants grown at 3% O2
[67], and metabolomic studies have demonstrated that
pre-eclamptic placental tissue grown under normoxic
conditions behaves similarly to control tissue grown
under hypoxia [123].
Another possibility is that the endothelial dysfunction
represents a biomarker of other underlying metabolic
abnormalitiesrelatedtocardiovasculardisease.However,
there is limited evidence that pre-eclampsia leads to
the metabolic syndrome in the offspring [18,124], with
no convincing evidence for changes in serum lipids or
glucose tolerance beyond acute transient changes in cord
blood samples [12,14,15,114,125–130]. Animal studies of
maternal hypoxia suggest that it is possible to induce
metabolic changes in animals exposed to a high-fat
diet, leading to increased serum leptin, triacylglycerols
(triglycerides), non-esteriﬁed (‘free’) fatty acids and
impaired glucose tolerance [131]. However, the need
for a secondary inducer would suggest that lipid and
glucose abnormalities are not fundamental features of the
underlying hypertensive cardiovascular phenotype.
Alternatively, the vascular changes could be inherited
between mother and child. Polymorphisms in certain
genes, such as those encoding eNOS, ACE (angiotensin-
convertingenzyme)andangiotensin,havebeenproposed
aspotentiallinks[132]underlyingthedevelopmentofthe
condition, although no consistent associations have been
found[133].Adverseexposuresduringfetallifecouldalso
lead to heritable characteristics through programming of
theepigenome,asthegreatestlevelofactiveprogramming
of the epigenome occurs during fetal life [134]. This
is clearly possible in humans, as placental DNA is
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hypomethylatedfollowingearly-,butnotlate-,onsetpre-
eclampsia [135,136] and imprinting of non-coding RNA
in placental tissue also differs in studies of pre-eclamptic
tissues [137]. As epigenetic changes are potentially
dynamic[138,139],thismechanismisofinterestasatarget
for intervention [140]. Transgenerational, potentially
epigenetic, effects are seen in ‘pre-eclampsia’ models.
Elevated BP is evident in the ﬁrst 12 weeks of life in
both male and female second-generation offspring born
to RUPP offspring [141]. Such transgenerational effects
are also evident in eNOS-knockout models as second-
generation offspring born to the eNOS-heterozygous
mothers, who developed in an in utero environment of
endothelial dysfunction, have increased BP compared
with those born to genetically similar mothers who had a
normal in utero development.
A potential stimulus for epigenetic programming is
hypoxia, which has been shown to induce a global
decrease in transcriptional activity in the vascular
endothelium [142]. Alternatively, the systemic maternal
oxidative stress evident during pre-eclampsia could alter
the delicate balance between the production of ROS
and cellular defences in the neonate. Oxidative stress
has been suggested to inﬂuence histone acetylation
and phosphorylation [143], telomere length [144] and
vascular gene expression. Some oxidative stress is
required for normal fetal development [145], but
the ischaemic pre-eclamptic placenta has signiﬁcantly
decreased total antioxidant capacity compared with the
normal placenta, and there is a correlation between
levels of oxidative stress in maternal peripheral blood
and cord blood in normotensive and pre-eclamptic
pregnancies [146,147], with levels signiﬁcantly higher
in pre-eclampsia [127,147]. The levels of oxidative
stress induced by pre-eclampsia itself are sufﬁcient to
cause damage to the fetus, as placental tissue samples
have higher levels of oxidative DNA damage in pre-
eclamptic pregnancies, whether or not there has been
fetal growth restriction [148]. This independent effect
of pre-eclampsia is not surprising, as fetal antioxidant
capacitygenerallyonlyincreasesinthelasttrimesterafter
the increase in oxidative stress observed in early-onset
pre-eclampsia [127,149]. Mitochondrial oxidative species
may be particularly relevant to this fetal programming
mechanism as, following pre-eclampsia, fetal-derived
HUVECs have impaired mitochondrial function [150]
associated with increased endothelial mitochondrial
oxidative species generation.
OTHER POTENTIAL MECHANISMS FOR
LONG-TERM PROGRAMING
Altered sympatho-adrenal function
It is also possible that the increased BP following in utero
exposure to pre-eclampsia is explained, in part, by non-
vascular alterations. The sympathetic nervous system has
a key role in regulating BP in humans and overactivity
may be associated with development of hypertension
[151]. Heart rate variability, a marker of autonomic
nervous system function, has been associated with and
precedes the development of several cardiovascular risk
factors, as well as being a predictor of mortality in high-
and low-risk populations [152]. Furthermore, alterations
in adrenal function have been associated with features
of the metabolic syndrome in adults [153]. Tenhola
et al. [14,154] have suggested that, in childhood, children
born to a pre-eclamptic mother have increased serum
adrenaline, but were not able to demonstrate differences
in other adrenal hormones. Despite this lack of human
data, there is some supportive evidence from animal
models. In particular, hypoxia studies have considered
sympatho-adrenal function in both fetal and post-natal
life. A chick embryo that has developed at high altitude,
and therefore has been exposed to signiﬁcant hypoxia
throughoutgestation,haselevatedplasmacorticotrophin,
decreased plasma corticosterone and elevated adrenal
adrenaline and noradrenaline compared with those
incubated at sea level [155]. Fetuses of pregnant ewes
who undergo gestation at high altitude similarly had
reduced adrenal mRNA for CYP (cytochrome P450) 17,
CYP11A1 and ACTH (corticotropin) [156], and higher
eNOS expression in the inner adrenal cortex [157]. There
is some evidence that these alterations in sympatho-
adrenal programming also persist through post-natal life,
as the offspring of Sprague–Dawley rats exposed to
hypoxia from pre-natal days 5–20 demonstrate persistent
alterations in the levels and utilization of catecholamines
in the heart and stellate ganglion at 12 weeks of age [72].
Even shorter exposures later in pregnancy may effect
adrenal function, as exposure of rat fetuses to 12% O2 in
thelast3 daysofgestationledtoalteredaldosteronelevels
at 7 days of age [158]. Further studies will be required
to elucidate whether this mechanism is signiﬁcant in
humans.
Renal dysfunction
Another possibility is that changes in renal function
are central to the programming of hypertension in
offspring of pre-eclamptic pregnancies. Offspring of the
rat RUPP model have inhibition of the RAS (renin–
angiotensin system), and bilateral renal denervation
normalizes their BP without inﬂuencing BP in control
animals [61,62]. RUPP offspring also have reductions
in glomerular number [57,65,159], increased glomerular
collagen deposition [86], increased glomerular volume
[57,159,160], altered renal VEGF expression [161] and
alterations in intrarenal renin and angiotensin expression
[61], although no difference in plasma renin activity has
been demonstrated [59,60,162]. At 18 months of age,
female RUPP offspring have increased plasma creatinine
and renal expression of TGF-β, MMP-9 and type VI
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collagen[65].Additionally,RUPPoffspringhavereduced
renal expression of the glucocorticoid receptor at day
21 after birth and increased mineralocorticoid receptor
expression at birth compared with control animals
[160]. Similar ﬁndings have never been demonstrated in
humans,butconceivablythesechangeswouldberelevant
toBPcontrolandafurtherunderstandingofthepotential
role of pre-eclampsia-induced renal changes in humans
subjects requires investigation [163].
Altered immune function and
inﬂammation
Finally, evidence for a further non-vascular non-
hypertension pathway of relevance to cardiovascular
disease development in the offspring of pre-eclamptic
pregnancy has recently emerged. Integration of data
from genome-wide gene expression studies of pre-
eclamptic decidua basalis tissue with tissue from
subjects with a history of familial heart disease
has identiﬁed commonality between disease processes
and several differentially expressed genes relevant to
immune function and inﬂammatory responses [164].
These include NOD1 [NOD (nucleotide-binding and
oligomerization domain)-like receptor 1], which plays
a key role in intracellular innate immunity [165], and
SPPL2 (signal peptide peptidase-like 2), which has been
shown to play a role in the release of pro-inﬂammatory
cytokines [166]. Pre-eclampsia involves a range of key
immune responses at different stages of the syndrome
[34], with the ﬁnal symptomatic phase characterized
by an intense maternal systemic inﬂammatory response
[34]. Women who suffer from autoimmune conditions
are at an increased risk of developing pre-eclampsia
[167], and in animal models the transfer of activated Th1
cells or infusion of inﬂammatory cytokines induces pre-
eclampsia-like symptoms [168–170]. Inﬂammation has a
key role in cardiovascular disease, with inﬂammatory cell
inﬁltration of the vessel wall an early pathophysiological
stageinthedevelopmentofatheroscleroticcardiovascular
disease [171,172]. Interestingly, neonates born following
pre-eclamptic pregnancies have elevated IL (interleukin)-
8 and greater percentages of natural killer cells, reduced
number of T-cells and altered expression of the Fas/Fas
ligand in their umbilical cord blood [173–176]. However,
without longer term follow-up it is difﬁcult to determine
whether these changes reﬂect acute changes associated
with the pregnancy or long-term changes relevant to
disease. A single study of 5–8-year-old children born
to women who experienced pre-eclampsia showed no
difference in general systemic inﬂammation, assessed by
high-sensitivityCRP(C-reactiveprotein)[114],butmore
sophisticated immunological or inﬂammatory markers
were not considered. Nevertheless, given the growing
understandingoftheimportanceofinﬂammationandim-
mune function in the pathophysiology of pre-eclampsia
and cardiovascular disease, further investigation of these
factors may prove useful in understanding the links
between pre-eclampsia and offspring cardiovascular
health.
Gender differences and the effect of
hormonal status
In addition to other potential programming mechanisms,
some studies have suggested the association between
exposure to pre-eclampsia and alteration of offspring
phenotype may be sex-speciﬁc. Animal work suggests
that hormonal status may play some role in phenotypic
modulation. Lu et al. [78] have demonstrated that the
male offspring of sFlt-1-induced ‘pre-eclamptic’ mothers
demonstrated a sustained increase in BP from the ﬁrst
day of life, which was not shown in female offspring
[78]. The hormonal status of RUPP offspring may
play a signiﬁcant role, as castration of male RUPP
offspring has been demonstrated to normalize BP
[162], whereas ovarianectomy induced hypertension in
otherwise normotensive female RUPP offspring [60].
Such ﬁndings suggest that gender-speciﬁc hormone
expressionmaymediateoralterthephenotypeassociated
with exposure to adverse intra-uterine conditions. Some
human studies of BP in children born to pre-eclamptic
mothers have also demonstrated gender differences;
however, these differed with some showing elevation in
males and some in females [177–179]. A recent meta-
analysis of data considering BP in children born to pre-
eclamptic pregnancies has suggested that the phenotype
is similar in both males and females [18]. Despite this,
the ﬁndings from animal models arguably suggest that
gender-related changes in biology may require closer
investigationinrelationtootheraspectsofthephenotype
in human populations.
CONCLUSIONS
Pre-eclampsia has a long-term impact on the cardio-
vascular health of both mother and offspring. The
pre-eclamptic in utero environment is characterized
by reduced uterine perfusion, hypoxia, raised anti-
angiogenic factors and systemic oxidative stress, leading
to maternal endothelial dysfunction. Animal studies
support the potential relevance of these insults to
programming of offspring BP and, in combination with
human experimental studies, have demonstrated a range
of potential mechanisms for the hypertensive phenotype.
In particular, endothelial dysfunction is consistently
observed in offspring of both animal and human studies
well into adult life. The underlying programming of
vascular function may relate to ‘structural’, ‘hypoxic’
or ‘epigenetic’ programming of endothelial development
and physiology. In addition, complementary pathways
to disease development, including changes in cardiac
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function, accelerated atherogenesis or alterations in renal
and immune function, may emerge as relevant to later
diseaseinoffspringofpre-eclampticpregnancies.Greater
understandingofallofthesemechanismswillprovidethe
basis for future novel strategies to prevent cardiovascular
disease in this high-risk group.
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